Press Release Archives

February 22, 2022

Significant progress in Iconovo’s three strategic business areas Significant events 1 October – 31 December Iconovo signed an agreement…

December 14, 2021

Iconovo AB (publ), that develops complete inhalation products for a global market, has registered the subsidiary Iconovo Pharma AB with the…

December 3, 2021

Iconovo is recruiting two new team members to increase the company's commercialization and is now aiming for one to three new signed contracts…

November 19, 2021

Iconovo AB (publ), that develops complete inhalation products for a global market, and TOA Pharmaceutical Co., Ltd, which develops generic…

November 1, 2021

The Chinese Patent Office has announced the intention to grant a patent (Notice of Allowance) regarding Iconovo’s inhalation device ICOone. Iconovo…

October 29, 2021

New nasal inhaler has great potential in treatment of COVID-19 Key figures in TSEK unless otherwise indicated Jul-Sep 2021 Jul-Sep 2020 Jan-Sep…

September 20, 2021

Iconovo AB (publ), that develops complete inhalation products for a global market today annonces that the company´s Quality Management System…

August 26, 2021

Japan Patent Office has announced the intention to grant a patent (Notice of Allowance) regarding Iconovo’s inhalation device, ICOres. Iconovo…

August 24, 2021

Expanded agreement doubles royalty potential Key figures in TSEK unless otherwise indicated Apr-Jun 2021 Apr-Jun 2020 Jan-Jun 2021 Jan-Jun…

July 12, 2021

Iconovo AB (publ), a company developing complete inhalation products for a global market, today announced that it has received an order from the…